Cécile Faure-Conter Selected Research

Therapeutics

11/2023	Antiseizure effect of MEK inhibitor in a child with neurofibromatosis type 1-Developmental and epileptic encephalopathy and optic pathway glioma.
5/2023	Neurocognitive and radiological follow-up of children under 5 years of age treated for medulloblastoma according to the HIT-SKK protocol.
11/2020	Tumor Molecular Profiling: Pediatric Results of the ProfiLER Study.
1/2020	Exploring heterogeneity of adrenal cortical tumors in children: The French pediatric rare tumor group (Fracture) experience.
1/2020	Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study.
1/2020	Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma.
1/2019	Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers.
3/2018	[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer].
10/2017	Immature Ovarian Teratoma: When to Give Adjuvant Therapy?
1/2017	The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cécile Faure-Conter Research Topics

Disease

22	Neoplasms (Cancer) 03/2024 - 06/2015
5	Medulloblastoma 07/2023 - 01/2020
4	Rupture 11/2021 - 06/2015
3	Glioma (Gliomas) 11/2023 - 02/2023
3	Brain Neoplasms (Brain Tumor) 07/2023 - 01/2018
3	Teratoma (Teratoid Tumor) 01/2020 - 04/2013
3	Infertility (Sterility) 01/2019 - 07/2015
2	Ototoxicity 11/2021 - 07/2018
2	Adenocarcinoma 01/2019 - 03/2018
2	Ependymoma 01/2017 - 10/2016
1	Ewing Sarcoma (Sarcoma, Ewing) 03/2024
1	Rhabdomyosarcoma 03/2024
1	Hepatoblastoma 02/2024
1	Brain Diseases (Brain Disorder) 11/2023
1	Seizures (Absence Seizure) 11/2023
1	Drug Resistant Epilepsy 11/2023
1	Neurofibromatoses (Neurofibromatosis) 11/2023
1	Leukoencephalopathies 05/2023
1	Neurocognitive Disorders (Clerambault Syndrome) 05/2023
1	Exanthema (Rash) 03/2023
1	Bacteremia 02/2023
1	Fever (Fevers) 02/2023
1	Sepsis (Septicemia) 02/2023
1	Chronic Renal Insufficiency 11/2021
1	Primitive Neuroectodermal Tumors (PNET) 07/2021
1	Seminoma 02/2021
1	Germinoma 02/2021
1	Pinealoma (Pineoblastoma) 01/2020
1	Residual Neoplasm 01/2020
1	Nasopharyngeal Carcinoma 06/2019
1	Infections 01/2018
1	Respiratory Sounds (Crackle) 01/2018
1	Eczema 01/2018
1	Dysgerminoma 01/2018
1	Allergic Rhinitis 01/2018
1	Asthma (Bronchial Asthma) 01/2018
1	Ovarian Teratoma 10/2017
1	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 09/2017
1	Birth Weight (Birth Weights) 01/2017
1	Neuroblastoma 11/2016
1	Ascites 12/2015
1	Hypogonadism (Hypergonadotropic Hypogonadism) 07/2015
1	Leukemia 04/2014

Drug/Important Bio-Agent (IBA)

6	PlatinumIBA 11/2021 - 04/2013
4	Cisplatin (Platino)FDA LinkGeneric 02/2024 - 06/2015
3	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 11/2016
2	CateninsIBA 02/2024 - 11/2020
2	Cell-Free Nucleic AcidsIBA 07/2023 - 11/2016
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2020
2	Hormones (Hormone)IBA 01/2019 - 03/2018
1	Aldehyde DehydrogenaseIBA 03/2024
1	Ifosfamide FDA LinkGeneric 03/2024
1	NivolumabIBA 01/2024
1	Mitogen-Activated Protein KinasesIBA 11/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2023
1	NucleotidesIBA 07/2023
1	Methotrexate (Mexate)FDA LinkGeneric 05/2023
1	Phosphotransferases (Kinase)IBA 03/2023
1	Fluvastatin FDA Link 03/2023
1	Celecoxib (Celebrex)FDA Link 03/2023
1	CreatineIBA 03/2023
1	Bevacizumab (Avastin)FDA Link 02/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2023
1	Etoposide (VP 16)FDA LinkGeneric 11/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020
1	Carboplatin (JM8)FDA LinkGeneric 07/2018
1	Contraceptive Agents (Contraceptives)IBA 03/2018
1	PesticidesIBA 01/2018
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 09/2017
1	Coffee FDA Link 07/2017
1	TeaIBA 07/2017
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2017
1	vasectrin IIIIBA 01/2017
1	SaltsIBA 04/2013

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 03/2024 - 04/2013
11	Therapeutics 11/2023 - 10/2016
3	Neoadjuvant Therapy 02/2024 - 09/2017
3	Adjuvant Chemotherapy 01/2020 - 12/2015
2	Induction Chemotherapy 07/2021 - 06/2019
2	Contraindications 01/2019 - 03/2018
2	Hormonal Contraception 01/2019 - 03/2018
2	Contraception (Birth Control) 01/2019 - 03/2018
1	Cranial Irradiation 05/2023
1	Central Venous Catheters 02/2023
1	Craniospinal Irradiation 07/2021
1	Medical Day Care (Partial Hospitalization) 01/2018
1	Ambulatory Care (Outpatient Care) 09/2017
1	Aftercare (After-Treatment) 07/2015
1	Salpingo-oophorectomy 06/2015
1	Ovariectomy (Oophorectomy) 06/2015
1	Hematopoietic Stem Cell Transplantation 04/2014